K C Takarinda1, A D Harries2, T Mutasa-Apollo3, C Sandy3, T Murimwa3, O Mugurungi3. 1. AIDS & TB Unit, Ministry of Health & Child Welfare, Harare, Zimbabwe ; Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe. 2. International Union Against Tuberculosis and Lung Disease, Paris, France ; London School of Hygiene & Tropical Medicine, London, UK. 3. AIDS & TB Unit, Ministry of Health & Child Welfare, Harare, Zimbabwe.
Abstract
SETTING: All public health facilities in two provinces of Zimbabwe. OBJECTIVE: To determine, among tuberculosis (TB) patients with human immunodeficiency virus (HIV) registered in 2010, 1) the proportion started on antiretroviral treatment (ART), 2) the timing of ART in relation to the start of anti-tuberculosis treatment, and 3) whether timing of ART influenced anti-tuberculosis treatment outcomes. DESIGN: Retrospective cohort study. RESULTS: Of the 2655 HIV-positive TB patients, 1115 (42%) were documented as receiving ART. Of these, 178 (16%) started ART prior to anti-tuberculosis treatment. Of those who started after anti-tuberculosis treatment, 17% started within 2 weeks, 43% between 2 and 8 weeks and 40% after 8 weeks. Treatment success in the cohort was 82%, with 14% deaths before completion of anti-tuberculosis treatment. Not receiving ART during anti-tuberculosis treatment was associated with lower anti-tuberculosis treatment success (adjusted RR 0.70, 95%CI 0.53-0.91) and more deaths (adjusted RR 3.43, 95%CI 2.2-5.36). There were no differences in TB treatment outcomes by timing of ART initiation. CONCLUSION: ART uptake is low given the improved treatment outcomes in those put on ART during anti-tuberculosis treatment. Better integration of HIV and TB services is needed to ensure increased coverage and earlier ART uptake.
SETTING: All public health facilities in two provinces of Zimbabwe. OBJECTIVE: To determine, among tuberculosis (TB) patients with human immunodeficiency virus (HIV) registered in 2010, 1) the proportion started on antiretroviral treatment (ART), 2) the timing of ART in relation to the start of anti-tuberculosis treatment, and 3) whether timing of ART influenced anti-tuberculosis treatment outcomes. DESIGN: Retrospective cohort study. RESULTS: Of the 2655 HIV-positive TB patients, 1115 (42%) were documented as receiving ART. Of these, 178 (16%) started ART prior to anti-tuberculosis treatment. Of those who started after anti-tuberculosis treatment, 17% started within 2 weeks, 43% between 2 and 8 weeks and 40% after 8 weeks. Treatment success in the cohort was 82%, with 14% deaths before completion of anti-tuberculosis treatment. Not receiving ART during anti-tuberculosis treatment was associated with lower anti-tuberculosis treatment success (adjusted RR 0.70, 95%CI 0.53-0.91) and more deaths (adjusted RR 3.43, 95%CI 2.2-5.36). There were no differences in TB treatment outcomes by timing of ART initiation. CONCLUSION:ART uptake is low given the improved treatment outcomes in those put on ART during anti-tuberculosis treatment. Better integration of HIV and TB services is needed to ensure increased coverage and earlier ART uptake.
Authors: Rony Zachariah; Marie-Paule L Spielmann; Christina Chinji; Patrick Gomani; Victor Arendt; Nicola J Hargreaves; Felix M Salaniponi; Anthony D Harries Journal: AIDS Date: 2003-05-02 Impact factor: 4.177
Authors: Elena Losina; Ingrid V Bassett; Janet Giddy; Senica Chetty; Susan Regan; Rochelle P Walensky; Douglas Ross; Callie A Scott; Lauren M Uhler; Jeffrey N Katz; Helga Holst; Kenneth A Freedberg Journal: PLoS One Date: 2010-03-04 Impact factor: 3.240
Authors: Simon D Makombe; Mindy Hochgesang; Andreas Jahn; Hannock Tweya; Bethany Hedt; Stuart Chuka; Joseph Kwong-Leung Yu; John Aberle-Grasse; Olesi Pasulani; Christopher Bailey; Kelita Kamoto; Erik J Schouten; Anthony D Harries Journal: Bull World Health Organ Date: 2008-04 Impact factor: 9.408
Authors: R Zachariah; M Fitzgerald; M Massaquoi; A Acabu; D Chilomo; F M L Salaniponi; A D Harries Journal: Int J Tuberc Lung Dis Date: 2007-08 Impact factor: 2.373
Authors: Riitta A Dlodlo; Paula I Fujiwara; Zanele E Hwalima; Stanley Mungofa; Anthony D Harries Journal: J Int AIDS Soc Date: 2011-07-06 Impact factor: 5.396
Authors: Rony Zachariah; Anthony David Harries; Marcel Manzi; Patrick Gomani; Roger Teck; Mit Phillips; Peter Firmenich Journal: PLoS One Date: 2006-12-27 Impact factor: 3.240
Authors: Neeraj Raizada; Lakbir Singh Chauhan; B Sai Babu; Rahul Thakur; Ajay Khera; D Fraser Wares; Suvanand Sahu; D Bachani; B B Rewari; Puneet K Dewan Journal: PLoS One Date: 2009-06-22 Impact factor: 3.240
Authors: B Odume; I Pathmanathan; S Pals; K Dokubo; D Onotu; O Obinna; D Anand; J Okuma; E Okpokoro; S Dutt; E Ekong; N Chukwurah; P Dakum; H Tomlinson Journal: Univers J Public Health Date: 2017